Lung Transplantation in Chronic HCV Infection With Post Transplant EPCLUSA Treatment
Status:
Terminated
Trial end date:
2019-03-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether treatment with Epclusa
(sofosbuvir/velpatasvir) after lung transplantation in individuals with chronic hepatitis C
infection is feasible, safe and effective at curing HCV.